WO1997002030A1 - A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders - Google Patents
A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders Download PDFInfo
- Publication number
- WO1997002030A1 WO1997002030A1 PCT/IT1996/000129 IT9600129W WO9702030A1 WO 1997002030 A1 WO1997002030 A1 WO 1997002030A1 IT 9600129 W IT9600129 W IT 9600129W WO 9702030 A1 WO9702030 A1 WO 9702030A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solution
- alcohol
- retinoic acid
- glyco
- ester
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69636778T DE69636778D1 (en) | 1995-06-30 | 1996-06-27 | Cosmetic agent containing retinoic acid propylene glycol ester for use on the skin and medicines for the treatment of skin diseases, tumorous cells and bladder or nerve palsy |
AU62410/96A AU6241096A (en) | 1995-06-30 | 1996-06-27 | A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
EP96921075A EP0836476B1 (en) | 1995-06-30 | 1996-06-27 | A COSMETIC COMPOSITION comprising the glycopropyl ester of retinoic acid FOR SKIN APPLICATIONS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF skin diseases, TUMOROUS CELLS, BLADDER OR NERVE DISORDERS |
US08/997,986 US6319957B1 (en) | 1995-06-30 | 1997-12-24 | Method for treating skin |
US09/965,795 US20020037305A1 (en) | 1995-06-30 | 2001-10-01 | Cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95TO000551A IT1276459B1 (en) | 1995-06-30 | 1995-06-30 | COSMETIC COMPOSITIONS WITH ANTIMICOTIC PROPERTIES, EFFECTIVE AGAINST PSORIASIS AND HAIR LOSS AND COSMETIC METHOD FOR |
ITTO95A000551 | 1995-06-30 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/997,986 Continuation US6319957B1 (en) | 1995-06-30 | 1997-12-24 | Method for treating skin |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997002030A1 true WO1997002030A1 (en) | 1997-01-23 |
Family
ID=11413690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IT1996/000129 WO1997002030A1 (en) | 1995-06-30 | 1996-06-27 | A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
Country Status (6)
Country | Link |
---|---|
US (2) | US6319957B1 (en) |
EP (1) | EP0836476B1 (en) |
AU (1) | AU6241096A (en) |
DE (1) | DE69636778D1 (en) |
IT (1) | IT1276459B1 (en) |
WO (1) | WO1997002030A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000017143A1 (en) * | 1998-09-23 | 2000-03-30 | Khodor Ammar | Derivatives of phenantrene for medicinal use and a process for their preparation |
WO2000057900A2 (en) * | 1999-03-31 | 2000-10-05 | Oxford Biomedica (Uk) Limited | Factor for regulation of neurite growth |
WO2001075135A1 (en) * | 2000-03-30 | 2001-10-11 | Oxford Biomedica (Uk) Limited | Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
EP1230919A2 (en) * | 2001-02-12 | 2002-08-14 | Warner-Lambert Company | Use of a composition comprising a retinoid and an erb inhibitor in the preparation of a medicament for the treatment of retinoid skin damage |
US6482943B1 (en) | 1999-04-30 | 2002-11-19 | Slil Biomedical Corporation | Quinones as disease therapies |
EP1401417A1 (en) * | 2001-05-23 | 2004-03-31 | Medicis Pharmaceutical | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
ES2327201A1 (en) * | 2008-04-23 | 2009-10-26 | Ignacio Umbert Millet | Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin |
EP3090741A1 (en) * | 2015-02-06 | 2016-11-09 | Orlandi, Augusto | The direct fungistatic effect of all-transretinoic acid on candida albicans and aspergillus fumigatus |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090203628A1 (en) * | 2008-02-12 | 2009-08-13 | Jan Marini | Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition |
ES2378028B1 (en) | 2012-02-22 | 2013-02-18 | Ignacio Umbert Millet | Cosmetic composition for skin rejuvenation and corresponding procedure and uses |
US8603549B1 (en) | 2012-05-25 | 2013-12-10 | Svetlana Baker | Systems and methods for inhibiting formation of stretch marks |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB906000A (en) * | 1959-11-23 | 1962-09-19 | Hoffmann La Roche | Cosmetic compositions comprising vitamin-a derivatives |
US4247547A (en) * | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
WO1989000157A1 (en) * | 1987-06-29 | 1989-01-12 | Molecular Design International, Inc. | Esters of 13-trans-retinoic acid |
WO1989006977A1 (en) * | 1988-02-04 | 1989-08-10 | Board Of Regents, The University Of Texas System | Formulation and use of retinoids in treatment of cancer and other diseases |
EP0472225A2 (en) * | 1985-12-11 | 1992-02-26 | L V M H Recherche | Hydrated lammelar lipidic phases or liposomes containing tretinoid |
WO1993010754A1 (en) * | 1991-12-03 | 1993-06-10 | Smithkline Beecham Plc | Skin care composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR472225A (en) | 1913-05-20 | 1914-11-26 | Azulay Syndicate Ltd | Improvements in machines for the manufacture of objects or of material composed of rubber or other adhesive material and fiber |
US4216224A (en) * | 1978-09-22 | 1980-08-05 | Scott Eugene J Van | Methods and compositions for treating psoriasis with retinoyl compounds |
US5514672A (en) * | 1981-02-17 | 1996-05-07 | Bazzano; Gail S. | Use of retinoids and compositions containing same for hair growth |
US4677120A (en) * | 1985-07-31 | 1987-06-30 | Molecular Design International | Topical prodrugs for treatment of acne and skin diseases |
US5043356A (en) * | 1990-01-19 | 1991-08-27 | Fulton Jr James E | Composition and method for rejuvenating skin using vitamin A propionate |
US5498420A (en) * | 1991-04-12 | 1996-03-12 | Merz & Co. Gmbh & Co. | Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions |
US5686086A (en) * | 1992-07-13 | 1997-11-11 | Shiseido Co., Ltd. | External skin treatment composition |
-
1995
- 1995-06-30 IT IT95TO000551A patent/IT1276459B1/en active IP Right Grant
-
1996
- 1996-06-27 AU AU62410/96A patent/AU6241096A/en not_active Abandoned
- 1996-06-27 DE DE69636778T patent/DE69636778D1/en not_active Expired - Lifetime
- 1996-06-27 EP EP96921075A patent/EP0836476B1/en not_active Expired - Lifetime
- 1996-06-27 WO PCT/IT1996/000129 patent/WO1997002030A1/en active IP Right Grant
-
1997
- 1997-12-24 US US08/997,986 patent/US6319957B1/en not_active Expired - Fee Related
-
2001
- 2001-10-01 US US09/965,795 patent/US20020037305A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB906000A (en) * | 1959-11-23 | 1962-09-19 | Hoffmann La Roche | Cosmetic compositions comprising vitamin-a derivatives |
US4247547A (en) * | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
EP0472225A2 (en) * | 1985-12-11 | 1992-02-26 | L V M H Recherche | Hydrated lammelar lipidic phases or liposomes containing tretinoid |
WO1989000157A1 (en) * | 1987-06-29 | 1989-01-12 | Molecular Design International, Inc. | Esters of 13-trans-retinoic acid |
WO1989006977A1 (en) * | 1988-02-04 | 1989-08-10 | Board Of Regents, The University Of Texas System | Formulation and use of retinoids in treatment of cancer and other diseases |
WO1993010754A1 (en) * | 1991-12-03 | 1993-06-10 | Smithkline Beecham Plc | Skin care composition |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000017143A1 (en) * | 1998-09-23 | 2000-03-30 | Khodor Ammar | Derivatives of phenantrene for medicinal use and a process for their preparation |
WO2000057900A2 (en) * | 1999-03-31 | 2000-10-05 | Oxford Biomedica (Uk) Limited | Factor for regulation of neurite growth |
WO2000057900A3 (en) * | 1999-03-31 | 2001-02-15 | King S College London | Factor for regulation of neurite growth |
GB2365772A (en) * | 1999-03-31 | 2002-02-27 | Oxford Biomedica Ltd | Factor |
EP1762243A1 (en) * | 1999-03-31 | 2007-03-14 | Oxford Biomedica (UK) Ltd | Factor for regulation of neurite growth |
US6482943B1 (en) | 1999-04-30 | 2002-11-19 | Slil Biomedical Corporation | Quinones as disease therapies |
WO2001075135A1 (en) * | 2000-03-30 | 2001-10-11 | Oxford Biomedica (Uk) Limited | Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
EP1230919A3 (en) * | 2001-02-12 | 2002-12-18 | Warner-Lambert Company | Use of a composition comprising a retinoid and an erb inhibitor in the preparation of a medicament for the treatment of retinoid skin damage |
EP1230919A2 (en) * | 2001-02-12 | 2002-08-14 | Warner-Lambert Company | Use of a composition comprising a retinoid and an erb inhibitor in the preparation of a medicament for the treatment of retinoid skin damage |
EP1401417A1 (en) * | 2001-05-23 | 2004-03-31 | Medicis Pharmaceutical | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
EP1401417A4 (en) * | 2001-05-23 | 2006-09-13 | Medicis Pharmaceutical Corp | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
ES2327201A1 (en) * | 2008-04-23 | 2009-10-26 | Ignacio Umbert Millet | Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin |
WO2009130344A1 (en) * | 2008-04-23 | 2009-10-29 | Ignacio Umbert Millet | Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin |
EP3090741A1 (en) * | 2015-02-06 | 2016-11-09 | Orlandi, Augusto | The direct fungistatic effect of all-transretinoic acid on candida albicans and aspergillus fumigatus |
Also Published As
Publication number | Publication date |
---|---|
DE69636778D1 (en) | 2007-02-01 |
EP0836476B1 (en) | 2006-12-20 |
IT1276459B1 (en) | 1997-10-31 |
ITTO950551A1 (en) | 1996-12-30 |
US6319957B1 (en) | 2001-11-20 |
AU6241096A (en) | 1997-02-05 |
ITTO950551A0 (en) | 1995-06-30 |
EP0836476A1 (en) | 1998-04-22 |
US20020037305A1 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5851556A (en) | Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained | |
TW537900B (en) | A skin treatment comprising repeated topical application to structurally deteriorated skin of a skin water-vapor barrier disruption treatment effective to provide chronic disruption of the aged skin's water-vapor barrier said chronic disruption being | |
JP3112436B2 (en) | In particular, the use of honey as a keratolytic agent to improve the brightness of the skin facial and treat wrinkles | |
JP3640392B2 (en) | Dermatological composition | |
AU2002317053B2 (en) | Dermal therapy using phosphate derivatives of electron transfer agents | |
Bollag et al. | Retinoic acid: topical treatment of senile or actinic keratoses and basal cell carcinomas | |
JPH08505630A (en) | Pharmaceutical and skin cosmetic compositions containing equine colostrum | |
JP2000512298A (en) | Combination of acid protease enzyme and acid buffer and its use | |
EP0822816B1 (en) | Dermatological preparation for treating actinic keratoses | |
EP0836476B1 (en) | A COSMETIC COMPOSITION comprising the glycopropyl ester of retinoic acid FOR SKIN APPLICATIONS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF skin diseases, TUMOROUS CELLS, BLADDER OR NERVE DISORDERS | |
JPH10500396A (en) | Hygiene and cosmetic preparation for preventing and treating dermatosis, and method for obtaining the same | |
US6544502B2 (en) | Skin treatment with a water soluble antibiotic dissolved in an electrolyzed water | |
US20090197819A1 (en) | Compositions for improving and repairing skin | |
EP0531495B1 (en) | Therapeutic and cosmetic compositions for treatment of skin | |
US20060222689A1 (en) | Skin care compositions and methods | |
JP2001502346A (en) | Zinc salt of conjugated linoleic acid for the treatment of skin diseases | |
JP3590369B2 (en) | Cosmetic composition for preventing and treating acne containing cryptotanshinone | |
US20020176876A1 (en) | Topical therapeutic skin care system | |
JPH04500824A (en) | Skin treatment methods to reverse the effects of photoaging | |
JPH04230321A (en) | Dermatological composition containing cis-urocanic acid | |
US5240945A (en) | Method and compositions for treating acne | |
US7514070B2 (en) | Method for exfoliating skin | |
US20060115503A1 (en) | Composition, system and method for treatment of skin | |
US20050276766A1 (en) | Methods and compositions for increasing skin remodeling | |
JP3277033B2 (en) | Cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 08997986 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996921075 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996921075 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996921075 Country of ref document: EP |